Application of PLDR External Irradiation Combined With Immune Checkpoint Inhibitors in Recurrent Cervical Cancer
Conditions: Cervical Squamous Cell Carcinoma; Radiotherapy; Immunotherapy Interventions: Radiation: PLDR+Cardunizumab Sponsors: Anhui Provincial Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Cervical Cancer | Hospitals | Immunotherapy | Research | Skin Cancer | Squamous Cell Carcinoma